SCHEMBL3104839

SCHEMBL3104839

CC(C)NC(=O)CNC(=O)c1ccc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)c2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 8/20 0.38
FAP Q12884 3/20 0.38
PSMB5 P28074 6/20 0.35
PSMB1 P20618 4/20 0.35
PSMB2 P49721 4/20 0.35
PSMB8 P28062 4/20 0.35
PSMB9 P28065 4/20 0.35
PSMB6 P28072 4/20 0.35
PSMB10 P40306 4/20 0.35
PSMB11 A5LHX3 3/20 0.35
PSMA7 O14818 3/20 0.35
PSMA1 P25786 3/20 0.35
PSMA2 P25787 3/20 0.35
PSMA3 P25788 3/20 0.35
PSMA4 P25789 3/20 0.35
PSMA5 P28066 3/20 0.35
PSMB4 P28070 3/20 0.35
PSMB3 P49720 3/20 0.35
PSMA6 P60900 3/20 0.35
PSMA8 Q8TAA3 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3104661 0.95 FAP (0.35) GPR139FAPPSMB5PSMB1PSMB2
SCHEMBL3106700 0.92 GPR139 (0.35) GPR139FAPPSMB5PSMB1PSMB2
SCHEMBL3113552 0.91 GPR139 (0.35) GPR139FAPPSMB5PSMB1PSMB2
SCHEMBL3120520 0.91 GPR139 (0.35) GPR139FAPPSMB5PSMB1PSMB2
SCHEMBL3096698 0.90 FAP (0.38) GPR139FAPPSMB5PSMB1PSMB2
SCHEMBL3113907 0.90 PDK2 (0.32) GPR139FAPMEN1KMT2A
SCHEMBL3111715 0.89 FAP (0.38) GPR139FAPPSMB5PSMB8
SCHEMBL3108150 0.89 PDK2 (0.34) GPR139FAPMEN1KMT2A
SCHEMBL3113195 0.89 PTGES (0.32) FAPMEN1KMT2AATM
SCHEMBL20117288 0.89 PTGES (0.32) FAPMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3222618-B1 NAPTHALENE ISOXAZOLINE INVERTEBRATE PEST CONTROL AGENTS DU PONT (US) 2020-09-09 EP disclosed
EP-3222618-A1 NAPTHALENE ISOXAZOLINE INVERTEBRATE PEST CONTROL AGENTS E. I. du Pont de Nemours and Company (US) 2017-09-27 EP disclosed
US-20140113943-A9 Naphthalene Isoxazoline Invertebrate Pest Control Agents E.I. DU PONT DE NEMOURS AND COMPANY 2014-04-24 US disclosed
US-20130217736-A1 Naphthalene Isoxazoline Invertebrate Pest Control Agents DU PONT (US) 2013-08-22 US disclosed
US-8410153-B2 Naphthalene isoxazoline invertebrate pest control agents E.I. DU PONT DE NEMOURS AND COMPANY (US) 2013-04-02 US disclosed
US-20100254959-A1 NAPHTHALENE ISOXAZOLINE INVERTEBRATE PEST CONTROL AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-07 US disclosed
EP-2158188-A2 NAPHTHALENE ISOXAZOLINE INVERTEBRATE PEST CONTROL AGENTS E. I. Du Pont de Nemours and Company (US) 2010-03-03 EP disclosed
WO-2009002809-A2 NAPHTHALENE ISOXAZOLINE INVERTEBRATE PEST CONTROL AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100254959-A1 NAPHTHALENE ISOXAZOLINE INVERTEBRATE PEST CONTROL AGENTS C1S, C1R, C9 GPR139 1150/4885FAP 3882/4885PSMB5 618/4885
US-20130217736-A1 Naphthalene Isoxazoline Invertebrate Pest Control Agents C1S, C1R, C9 GPR139 1150/4885FAP 3882/4885PSMB5 618/4885
US-20140113943-A9 Naphthalene Isoxazoline Invertebrate Pest Control Agents C1S, C1R, C9 GPR139 1150/4885FAP 3882/4885PSMB5 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.